Results 181 to 190 of about 50,800 (294)

Mitochondrial Carrier SLC25A13 Drives Ferroptosis Resistance and Immune Evasion via a STAT3–IFI6 Circuit in Breast Cancer

Advanced Science, EarlyView.
SLC25A13 is identified as an immunometabolic driver of triple‐negative breast cancer that sustains ferroptosis resistance and immune evasion through a STAT3–IFI6 circuit. Pharmacologic degradation of SLC25A13 restores ferroptosis sensitivity and enhances anti‐PD‐1 efficacy, highlighting a strategy to convert immune‐cold tumors into immunotherapy ...
Yingze Zhu, Yuhan Tang, Yingcui Chen, Zhuoqi Zhang, Yige Lu, Xinyue Wang, Qiyuan Shi, Wenhui Zhao, Hui Pang   +8 more
wiley   +1 more source

Expression profiles and clinical significance of cystatin family genes in transitional cell carcinoma of the urinary bladder. [PDF]

Bladder (San Franc)
Xu H, Liu W, Kuang X, Zhao J, Wang X, Li B.   +5 more
europepmc   +1 more source

Expression of proto-oncogene c-Myc in patients with urinary bladder transitional cell carcinoma. [PDF]

Curr Urol, 2021
Fragkoulis C, Ntoumas G, Glykas I, Papadopoulos G, Stathouros G, Kostopoulou A, Choreftaki T, Ntoumas K.   +7 more
europepmc   +1 more source

MiR‐940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes

Advanced Science, EarlyView.
A CRISPR‐based screening identified miR‐940 as a critical suppressor of ferroptosis in cancer. By coordinating the downregulation of pro‐ferroptotic genes with the upregulation of GPX4, miR‐940 establishes a regulatory network that protects against ferroptosis and correlates with poor clinical outcomes in distinct cancer entities.
Andrea Kolak, Juliane Tschuck, Stefanie A. I. Weiß, Daniel Kaemena, Karolin Klimm, Ana Galhoz, Larissa Ringelstetter, Myles Fennell, Juliane Merl‐Pham, Anna Artati, Stefanie Strasser, Ralph Garippa, Michael Witting, Hans Zischka, Joel A. Schick, Stefanie M. Hauck, Michael P. Menden, Michelle Vincendeau, Brent R. Stockwell, Kamyar Hadian   +19 more
wiley   +1 more source

Uncommon presentation of transitional cell carcinoma: A case report of hand involvement. [PDF]

Clin Case Rep
Sanei-Far Z, Gharib M.
europepmc   +1 more source

Survey of Mast Cell Density in Transitional Cell Carcinoma. [PDF]

Iran J Pathol, 2021
Moradi Tabriz H, Obohat M, Vahedifard F, Eftekharjavadi A.   +3 more
europepmc   +1 more source

Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?

, 1997
PURPOSE: We determined if urethral preservation and orthotopic bladder replacement in patients with transitional cell carcinoma within the prostatic urethra or prostate placed these patients at risk for urethral recurrence or death. MATERIALS AND METHODS:
Webster, G D, Robertson, C N, Paulson, D F, Vieweg, Johannes, Iselin, C E   +4 more
core  

IKKβ and USP28 Regulate HEY1 Stability to Promote Cancer Stemness and Immune Evasion in Hepatocellular Carcinoma

Advanced Science, EarlyView.
The uncovered IKKβ‐USP28‐HEY1 axis fuels cancer stemness and immune evasion in hepatocellular carcinoma. USP28 deubiquitinates HEY1 upon IKKβ‐mediated phosphorylation, conferring PD‐1/PD‐L1 blockade resistance. Pharmacological inhibition of USP28 sensitizes resistant tumors to anti‐PD‐1 immunotherapy, revealing a promising therapeutic strategy ...
Na Shao, Lin Zhang, Gufang Shen, Yangfan Lv, Tianshu Fang, Ya Cao, Qiongyi Zhang, Feng Xu, Chungang Liu   +8 more
wiley   +1 more source

Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney. [PDF]

Curr Urol
Gaines JM, Macdonald EJ, Rai A, Hoenig D, Smith A, Okeke Z, Aro T.   +6 more
europepmc   +1 more source

Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells. [PDF]

In Vivo, 2022
Alnajjar S, Nolte I, Schille JT, Sender S, Trakoolju N, Perez SV, Zechner D, Vollmar B, Junghanss C, Murua Escobar H.   +9 more
europepmc   +1 more source